Carnick & Kubik, LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 11 quarters from 2013-06-30 to 2016-03-31, Carnick & Kubik, LLC opened 17 positions, added to 19, reduced 4 and sold out of 9.
- Q4 2015: Stock NVO; Country of operation —; Class ADR; Shares before 26,095.
- Q4 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 12,400.
- Q4 2015: Stock SNY; Country of operation —; Class SPONSORED ADR; Shares before 9,555.
- Q3 2015: Stock NVO; Country of operation —; Class ADR; Shares before 22,540.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1555900), 11 quarters: Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-12); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-11); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-30); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-06); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-03); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-04); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-05); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-06); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-29). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2015 | NVO
NOVO-NORDISK A S | | ADR | 26,095 | 27,534 | +1,439 | $1,415,393,000 | $1,599,000 | -$1,413,794,000 | 2016-02-11 |
|---|
| Q4 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 12,400 | 13,009 | +609 | $700,104,000 | $854,000 | -$699,250,000 | 2016-02-11 |
|---|
| Q4 2015 | SNY
SANOFI | | SPONSORED ADR | 9,555 | 10,751 | +1,196 | $453,576,000 | $459,000 | -$453,117,000 | 2016-02-11 |
|---|
| Q3 2015 | NVO
NOVO-NORDISK A S | | ADR | 22,540 | 26,095 | +3,555 | $1,234,000 | $1,415,393,000 | +$1,414,159,000 | 2015-11-13 |
|---|
| Q3 2015 | SNY
SANOFI | | SPONSORED ADR | 9,180 | 9,555 | +375 | $455,000 | $453,576,000 | +$453,121,000 | 2015-11-13 |
|---|
| Q2 2015 | SNY
SANOFI | | SPONSORED ADR | 9,130 | 9,180 | +50 | $451,000 | $455,000 | +$4,000 | 2015-07-30 |
|---|
| Q1 2015 | NVO
NOVO-NORDISK A S | | ADR | 21,390 | 22,550 | +1,160 | $905,000 | $1,204,000 | +$299,000 | 2015-05-06 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 10,150 | 10,225 | +75 | $584,000 | $637,000 | +$53,000 | 2015-05-06 |
|---|
| Q1 2015 | SNY
SANOFI | | SPONSORED ADR | 9,005 | 9,130 | +125 | $411,000 | $451,000 | +$40,000 | 2015-05-06 |
|---|
| Q4 2014 | NVO
NOVO-NORDISK A S | | ADR | 21,375 | 21,390 | +15 | $1,018,000 | $905,000 | -$113,000 | 2015-02-03 |
|---|
| Q4 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 9,450 | 10,150 | +700 | $508,000 | $584,000 | +$76,000 | 2015-02-03 |
|---|
| Q4 2014 | SNY
SANOFI | | SPONSORED ADR | 8,280 | 9,005 | +725 | $467,000 | $411,000 | -$56,000 | 2015-02-03 |
|---|
| Q3 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 14,650 | 14,750 | +100 | $664,000 | $618,000 | -$46,000 | 2014-11-04 |
|---|
| Q3 2014 | NVO
NOVO-NORDISK A S | | ADR | 21,205 | 21,375 | +170 | $979,000 | $1,018,000 | +$39,000 | 2014-11-04 |
|---|
| Q2 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 13,950 | 14,650 | +700 | $597,000 | $664,000 | +$67,000 | 2014-08-05 |
|---|
| Q2 2014 | SNY
SANOFI | | SPONSORED ADR | 8,580 | 8,930 | +350 | $449,000 | $475,000 | +$26,000 | 2014-08-05 |
|---|
| Q1 2014 | NVO
NOVO-NORDISK A S | | ADR | 20,555 | 21,205 | +650 | $3,797,742,000 | $968,000 | -$3,796,774,000 | 2014-05-06 |
|---|
| Q1 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 13,850 | 13,950 | +100 | $570,620,000 | $597,000 | -$570,023,000 | 2014-05-06 |
|---|
| Q4 2013 | SNY
SANOFI | | SPONSORED ADR | 8,615 | 8,990 | +375 | $436,000 | $482,134,000 | +$481,698,000 | 2014-02-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |